Restoring Dystrophin via Exon Skipping Strategies AOC 1044 – Mark Stahl, MD (Avidity Biosciences) BMN 351 – Dave Jacoby MD, PhD (BioMarin Pharmaceutical Inc.) DYNE-251 – Ash Dugar, PhD, MBA (Dyne Therapeutics) ED051 – Michelle Mellion, MD (PepGen, Inc.) ENTR-601-44 – Nerissa Kreher, MD, MBA (Entrada Therapeutics) SRP-5051 – Teji Singh, MD (Sarepta Therapeutics) WVE-N531 – Mike Panzara, MD, MPH (Wave Life Sciences) 2022 PPMD Annual Conference,Conferences & Meetings 2 years ago You may also like 31:10 The Landscape of Cardiac Care: Emerging Therapies on the Horizon — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 54:15 Emergency Care in Duchenne — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 8:36 Here Is What I Hear — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 39:20 The Future of Genetic Therapies — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 1:30:40 Gene Therapy Approaches to Replace or Restore Dystrophin — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 25:56 Gene Therapy Era: What We Know — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 32:14 Duchenne Siblings Panel: What We Want You To Know — PPMD 2022 Annual Meeting 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 34:37 Parent Panel: Things I’d Like My Doctor To Know — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings «1…7891011…25»Page 9 of 25
by: Parent Project Muscular Dystrophy
